A. Gatsiou

发表

Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation

H. Schwalbe, A. Franco‐Cereceda, P. Eriksson, 2016, Nature Medicine.

Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile

T. Biedermann, F. Ziemssen, K. Stellos, 2015, Ophthalmologica.

Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.

Christoph Laske, Stefanie Dimmeler, Kimon Stamatelopoulos, 2015, Journal of the American College of Cardiology.

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.

A. Khera, C. Ayers, J. D. de Lemos, 2018, Journal of the American College of Cardiology.

Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

F. Bonini, E. Giannitsis, I. Spyridopoulos, 2022, Journal of the American College of Cardiology.

RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease

A. Gatsiou, M. Sachse, Maria Birgaoanu, 2022, Cardiovascular Drugs and Therapy.

Beta-Secretase-1 Antisense RNA Is Associated with Vascular Ageing and Atherosclerotic Cardiovascular Disease

F. Martelli, K. Stamatelopoulos, S. Tual-Chalot, 2022, Thrombosis and haemostasis.

RNA modifications in cardiovascular health and disease

K. Stellos, A. Gatsiou, 2022, Nature Reviews Cardiology.

RNA Therapeutics in Cardiovascular Precision Medicine

K. Stamatelopoulos, K. Stellos, A. Gatsiou, 2018, Front. Physiol..

RNA-binding proteins in vascular inflammation and atherosclerosis.

K. Stamatelopoulos, S. Tual-Chalot, K. Stellos, 2023, Atherosclerosis.

MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation.

J. Boeckel, K. Stellos, A. Gatsiou, 2012, Current vascular pharmacology.

Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets

D. Stakos, K. Stamatelopoulos, K. Stellos, 2013, Platelets.

Adenosine-to-Inosine RNA Editing in Health and Disease.

K. Stellos, A. Gatsiou, F. F. Lunella, 2017, Antioxidants & redox signaling.

Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State

K. Stellos, A. Gatsiou, K. Sopova, 2021, Cells.

Increased adenosine-to-inosine RNA editing in rheumatoid arthritis

Petros P. Sfikakis, Angela Gallo, Kimon Stamatelopoulos, 2020, Journal of autoimmunity.

Dawn of Epitranscriptomic Medicine.

K. Stellos, A. Gatsiou, 2018, Circulation. Genomic and precision medicine.

Amyloid- (1-40) and Mortality in Patients With NonST-Segment Elevation Acute Coronary Syndrome

A. Zeiher, S. Dimmeler, H. Katus, 2018, Annals of Internal Medicine.

Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.

C. Laske, D. Stakos, K. Stamatelopoulos, 2014, Journal of Alzheimer's disease : JAD.

Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis

M. Dimopoulos, I. Lambrinoudaki, I. Andreadou, 2019, Circulation research.

Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis.

H. Hermeking, F. Bonini, A. Zeiher, 2021, Atherosclerosis.

Endothelial dysfunction and immunothrombosis in sepsis

K. Stamatelopoulos, S. Tual-Chalot, K. Stellos, 2023, Frontiers in Immunology.

Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis

F. Bonini, P. Sfikakis, K. Stamatelopoulos, 2021, Journal of autoimmunity.

The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation.

C. Trautwein, A. Waisman, M. Sperandio, 2023, Immunity.

Influence of aflibercept on platelet activation profile

K. Schenke-Layland, T. Biedermann, F. Ziemssen, 2018, Experimental eye research.

Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease

F. Bonini, K. Stamatelopoulos, K. Stellos, 2021, Journal of molecular and cellular cardiology.

Clinical frailty, and not features of acute infection, is associated with late mortality in COVID‐19: a retrospective cohort study

I. Spyridopoulos, K. Stamatelopoulos, S. Tual-Chalot, 2022, Journal of cachexia, sarcopenia and muscle.

Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction

A. Turchinovich, Ashfaq Mohammad, I. Spyridopoulos, 2023, Frontiers in Immunology.

Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease

K. Stamatelopoulos, A. Koureas, S. Tual-Chalot, 2019, European Journal of Preventive Cardiology.